Try our beta test site
204 studies found for:    "Osteoporosis, Postmenopausal"
Show Display Options
Rank Status Study
21 Completed Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: disodium clodronate 200 mg/4 ml with 1% lidocaine;   Drug: Disodium clodronate 100 mg/3,3 ml with 1% lidocaine
22 Completed ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
Condition: Post Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
23 Completed SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
Condition: Post Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
24 Completed
Has Results
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
Condition: Post Menopausal Osteoporosis
Interventions: Drug: Ibandronate [Bonviva/Boniva];   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D
25 Completed
Has Results
A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis
Condition: Post Menopausal Osteoporosis
Intervention: Drug: Ibandronate
26 Completed
Has Results
A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis
Condition: Post Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
27 Completed
Has Results
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
28 Completed
Has Results
A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: ibandronate [Bonviva/Boniva]
29 Completed
Has Results
BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
Condition: Post-Menopausal Osteoporosis
Intervention: Drug: Ibandronate
30 Completed
Has Results
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Condition: Post Menopausal Osteoporosis
Interventions: Drug: Risedronate;   Drug: ibandronate [Bonviva/Boniva]
31 Completed Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: risedronate (HMR4003)
32 Completed Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis
Conditions: Postmenopausal Osteoporosis;   Compliance
Interventions: Drug: Raloxifene;   Drug: Strontium ranelate
33 Completed CLCF1 Gene Associated With Postmenopausal Osteoporosis of Kidney Yin Deficiency Syndrome
Condition: Postmenopausal Osteoporosis
Intervention: Other: Liuwei Dihuang Pill
34 Completed Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.
Condition: Postmenopausal Osteoporosis
Interventions: Drug: Bazedoxifene;   Drug: Placebo
35 Completed A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Ibandronate
36 Completed Wellnara Post-marketing Surveillance in Japan
Condition: Osteoporosis, Postmenopausal
Intervention: Drug: E2/LNG oral (Wellnara, BAY86-5029)
37 Completed Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Interventions: Drug: AMG 785;   Drug: Placebo;   Drug: Denosumab
38 Completed Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: Bazedoxifene;   Drug: Calcium/Vit D
39 Completed Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women
Condition: Osteoporosis Postmenopausal
Intervention: Drug: Risedronate (HMR4003)
40 Recruiting Peri-implant Bone Changes in Post-menopausal Osteoporotic Women
Condition: Osteoporosis, Postmenopausal
Intervention: Device: Dental implant placement (Straumann® Bone Level Tapered, BLT, Roxolid® SLActive®)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.